Back to results
CompletedPhase 1Phase 2

Dapagliflozin In Alzheimer's Disease

NCT03801642

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Kansas Medical Center

Kansas City, Kansas, United States

View on ClinicalTrials.gov
Dapagliflozin In Alzheimer's Disease — TrialFind